Full Description
This volume provides a comprehensive, state-of-the art review of the field of cell therapy. The volume begins with an overview of the breadth of the field and then turns to overviews of imaging technologies that can aid in both safety and efficacy evaluations. The book then turns to numerous contributions detailing the rapidly growing field of stem cell therapies. These sections cover our understanding of the natural roles of stem cells in biology and human disease and then touches on several of the more prominent areas where stem cells are moving rapidly into clinical evaluation including neurodegenerative diseases, muscular dystrophy, cardiac repair, and diabetes. The volume concludes with contributions from experts in oncology, ophthalmology, stem cells, 3-D printing, and biomaterials where the convergence of expertise is leading to unprecedented insights into how to minutely control the in vivo fate and function of transplanted and/or endogeneously mobilized cells. Finally, the book provides insights into the pivotal relationship between academic and industrial partnerships.
This volume is designed to touch on the major areas where the field will make its greatest and most immediate clinical impacts. This text will provide a useful resource for physicians and researchers interested in the rapidly changing filed of cell therapy.
Contents
Molecular Considerations in Cell Transplant Imaging.- Considerations for Successful Encapsulated β Cell Therapy.- Stem Cell Therapy for Neurovascular and Traumatic Brain Diseases.- Cell Replacement Strategies for Parkinson's Disease.- Cell Therapy for Epilepsy.- Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions.- Encapsulation Approaches to Cell Therapy.- Biomaterials and Cells for Re-Vascularization.- Cell Reprogramming for Cardiac Regeneration and Rare Disease Modeling.- Engineering Organoid Systems to Model Health and Disease.- 3D Printing for Cell Therapy Applications.- Cell Therapy for Ophthalmic Diseases.- Cell Therapy: Approaching a Partnership with Pharma.- Stem Cell Therapy in Duchenne Muscular Dystrophy
